Blueprint Medicines

Blueprint Medicines

+

AYVAKIT |

Blueprint Medicines + AYVAKIT |


Systemic Mastocytosis is a rare disease that can be incredibly difficult to diagnose. So, we launched an unbranded campaign to help raise awareness and make the disease state feel less isolating.

And on the branded side, we tackled the ISM (Indolent Systemic Mastocytosis) indication by promoting Ayvakit as a safe and effective approach to everyday life with the disease — a life worth looking forward to.